Olivier de Beaumont

Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France.

Part of Stallergenes Greer Ltd., Stallergenes Greer, Inc. specializes in the development and commercialization of allergy immunotherapy products for use in the diagnosis and treatment of allergies. The company is based in Cambridge, MA.